Biopsy Device Manufacturing
ENGINEERED FOR PRECISION. SCALED FOR PERFORMANCE
Engineered for Precision. Scaled for Performance
Biopsy devices demand absolute consistency. From precision molded components and complex assemblies to high-force mechanical performance, even the smallest variation can impact device reliability and clinical outcomes.
SMC partners with leading healthcare companies to bring complex biopsy systems into scalable manufacturing faster, combining precision injection molding, automation, assembly expertise, and process control to support programs from development through commercial production.
Comprehensive Support for Clinical Trials and Commercialization
Manufacturing Biopsy Devices at Scale Requires More Than Capacity
Building biopsy devices isn’t the challenge. Building devices that perform the same way every single time — at production scale — is where complexity increases.
Biopsy systems combine intricate mechanical assemblies, molded components, springs, metal inserts, and precision cutting mechanisms that must operate with repeatable accuracy under high mechanical stress. Small inconsistencies in materials, tolerances, or assembly processes can directly affect firing performance, sample quality, and overall device reliability.
SMC helps customers bridge the gap between development and scalable manufacturing by integrating engineering, molding, automation, assembly, and process validation into a structured manufacturing approach designed for speed, precision, and execution.
Key Manufacturing Challenges in Biopsy Devices:
Tolerance Management Across Complex Assemblies
Biopsy devices integrate plastics, metals, springs, and precision components where cumulative dimensional variation can affect alignment, firing accuracy, and device performance.
Consistent Mechanical Performance
Spring-driven and cutting mechanisms require highly repeatable force and timing characteristics to ensure consistent sample collection and device reliability at scale.
Precision Overmolding and Material Adhesion
Combining metal cannulas and molded plastic components requires advanced expertise in adhesion optimization, insert molding, and process control to maintain pull-force and durability requirements.
Automation and High-Risk Component Handling
Sharp, high-value components require specialized automation, protective handling systems, and precision assembly processes to minimize scrap while maintaining throughput and operator safety.
Process Validation and Regulatory Readiness
Every process step must be validated, traceable, and repeatable. Manufacturing systems need to support global regulatory requirements without slowing commercialization timelines.
Speed to Market Without Sacrificing Control
Scaling quickly requires manufacturing processes designed for repeatability from the start — reducing downstream delays, variability, and costly rework.
Integrated Manufacturing Capabilities for Biopsy Systems
SMC combines vertically integrated manufacturing capabilities with healthcare-focused expertise to support complex biopsy device programs from development through commercialization.
Precision Injection Molding
- High-precision molding capabilities for complex device components, including insert molding and overmolding of metal components.
Functional Testing and Verification
- Integrated inspection, force testing, and performance verification systems designed to ensure repeatable device functionality at scale.
Design for Manufacturability (DFM)
- Cross-functional engineering collaboration to improve manufacturability, scalability, yield, and long-term production stability early in development.
Automation and Assembly
- Semi-automated and fully automated assembly systems designed for high repeatability, complex assembly sequences, and integrated process verification.
Precision Handling of Sharps and Critical Components
- Advanced handling systems for sharpened cannulas, metal inserts, and high-value components requiring controlled assembly environments.
Global Manufacturing Support
- Scalable manufacturing support through SMC’s global healthcare manufacturing footprint and vertically integrated operations.
Explore Case Studies, Articles and Other Resources
-
Combining Human Needs With High Viscosity Formulations
Within the injectable drug landscape, the availability and usage of high viscosity (HV) drugs is growing, often driven by developments such as long-acting injectable (LAI) technologies. Currently, these products provide significant advantages in terms of more convenient dosage volumes for patients and healthcare professionals (HCPs). With a trend towards self-administration, LAIs allow for less frequent
-
Finding the Ideal Balance: “Where Risk and Cost of Quality Meet”
What is the answer to improve value for customers and reducing overall costs? Part of the answer resides within the functional activities of risk and cost of quality management. These critical processes are needed to reach and maintain the optimum operating space, and provide the value customers seek. Common challenges to effectively pull these two
-
Insights Into Drug Delivery Device Manufacturing From Development Through Commercialization
With technology advancements and a greater understanding of effective treatment options, novel delivery methods are being introduced giving pharmaceutical companies a competitive edge and offering patients better solutions for their needs.